Board of Directors

The Board of Directors is responsible for Genovis’ long-term operations and the organization of the company.

Genovis’ Board consists of four members elected by the AGM. The Board meets five times a year according to the schedule adopted by the Board. In addition to regular meetings, the Board may also be convened as necessary.

Member of the Board of Directors since: 2020
Born: 1952
Education: B.Sc. in Economics, CBS
Shares in Genovis: 153,690 shares

Other Directorship

Chairman of the Board of Boule Diagnostics and Argus Eye AB. He also serves on the board of Nova Biomedical.

Relevant Work Experience

CEO and President of Biotage. Previous appointments include CEO and President of Biotage, Affibody AB, Karo Bio and DAKO A/S.

Independency: Independent in relation to the company, its management and the company’s major shareholders.

Last updated: Jan 28, 2026

Member of the board since: 2014
Born: 1949
Education: MD
Shares in Genovis: Holds 9,000,000 shares

Other Directorship

Chairman of the Board of Wingspan Company Culture AB, Oxlantic Medical AB and Thioredoxin Systems AB. He also serves on the boards of Annexin Pharmaceuticals AB, Mahatma Psykiatri AB, Redeye AB/Redhold AB, Vasa Angels 1 AB, Mikael Lönn AB and Collabodoc AB.

Relevant Work Experience

Mikael Lönn is a physician, entrepreneur and has been active as business leader, mainly in the health care sector. He has extensive experience of financial investments, providing consultancy services and participated on the board of directors for a number of startup and growth companies, as well as experience from large county council and municipal-owned organi­zations.

Independency: Independent in relation to the company’s management and its major shareholders but not in relation to the company.

Last updated: Jan 28, 2026

High-resolution image


Member of the board since: 2019
Born: 1961
Education: PhD Biochemistry
Shares in Genovis: 5,160 shares

Other Directorship

Board member of BioArctic AB, NorthX Biologics AB and BioLamina AB.

Relevant Work Experience

Former CEO of Testa Center, GE Nordics, IMED AB and global head of BioProcess R&D GE Healthcare Life Sciences. She has also held several project management positions at Biovitrum, Pharmacia Corp and Pharmacia & Upjohn.

Independency: Independent in relation to the company, its management and the company’s major shareholders.

Last updated: Jan 28, 2026

High-resolution image


Member of the board since: 2021
Born: 1953
Education: CChem FRSC
Shares in Genovis: 5,010 shares

Other Directorship

Steve Jordan has no other board assignments.

Relevant Work Experience

Steve is currently working as a consultant for several companies engaged in the development of novel technologies and materials for the life science industries. Prior experience includes Chief Scientific Officer and Senior Director R&D Chemistry at Biotage, Steve also has broad senior management experience from both large Pharma and life science companies and has extensive M&A experience gained in the industry.

Independency: Independent in relation to the company, its management and the company’s major shareholders.

Last updated: October 8, 2024

Member of the board since: 2022
Born: 1972
Education: MSc, MBA, PhD Medical Biochemistry and Biophysics
Shares in Genovis: 11,000 shares

Other Directorship

Board member of Immuneed AB.

Relevant Work Experience

Currently employed as Chief Commercial Officer at NorthX Biologics. He has more than 15 years of experience from different commercial positions such as and Head of Global Business Development at Biovian, Director Strategy; Search and Evaluation at Cytiva/GE Healthcare Life Sciences and as Corporate and Business Development Director at Cobra Biologics (now Charles River).

Independency: Independent in relation to the company, its management and the company’s major shareholders.

Last updated: Jan 28, 2026

  • Svenska